Edyta Niemczyk Selected Research

vanillyl-N-nonylamide

1/2004

A possible involvement of plasma membrane NAD(P)H oxidase in the switch mechanism of the cell death mode from apoptosis to necrosis in menadione-induced cell injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Edyta Niemczyk Research Topics

Disease

6	Osteosarcoma (Osteogenic Sarcoma) 02/2007 - 01/2004
5	Necrosis 02/2007 - 01/2004
1	Choriocarcinoma 01/2004

Drug/Important Bio-Agent (IBA)

5	Vitamin K 3 (Menadione)FDA Link 02/2007 - 01/2004
4	Superoxides (Superoxide)IBA 02/2007 - 01/2004
2	Adenosine Triphosphate (ATP)IBA 02/2007 - 04/2005
2	Pharmaceutical PreparationsIBA 06/2004 - 01/2004
2	NADPH Oxidases (NAD(P)H oxidase)IBA 06/2004 - 01/2004
2	StaurosporineIBA 01/2004 - 01/2004
1	Free RadicalsIBA 04/2005
1	OligomycinsIBA 04/2005
1	Propidium (Propidium Iodide)IBA 06/2004
1	Fluorescein-5-isothiocyanate (FITC)IBA 06/2004
1	Annexin A5IBA 06/2004
1	Actins (F Actin)IBA 01/2004
1	jasplakinolideIBA 01/2004
1	acetovanillone (apocynin)IBA 01/2004
1	latrunculin A (LAT-A)IBA 01/2004
1	vanillyl-N-nonylamideIBA 01/2004
1	Coloring Agents (Dyes)IBA 01/2004
1	diphenyliodoniumIBA 01/2004